Andrew Kin

Andrew Kin

Andrew Kin

Position Title

Assistant Professor - Clinical
Hematology-Oncology

Office Location

Karmanos Cancer Institute
Hudson-Webber Cancer Research Center
4100 John R.
Detroit, MI 48201

 

Mailing Address

Karmanos Cancer Institute
4100 John R., HW04HO
HWCRC - 4245
Detroit, MI 48201

Office Phone

313-576-8744

Office Fax

313-576-8767

Education Training

(2008-2012) Medical Doctorate, University of Cincinnati College of Medicine, Cincinnati, OH
(2002-2006) Bachelor of Science in Molecular Genetics with Honors, cum laude, The Ohio State University, Columbus, OH

Postgraduate Training
(2015-2018) Fellowship, Hematology/Oncology, Karmanos Cancer Institute/ Wayne State University/ Detroit Medical Center, Detroit, MI
(2012-2015)  Internship/Residency, Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
 

 

Professional Experience

Faculty Appointments
(2018-Present) Assistant Professor - Clinical, Department of Oncology, Wayne State University School of Medicine, Detroit, MI

Hospital or Other Professional Appointments
(2006-2008) Basic Researcher: Uveal melanoma laboratory, The Ohio State University Wexner Medical Center, Columbus, OH
 

 

Major Professional Societies

(2015-Present) American Society of Clinical Oncology (ASCO)
(2015-Present) American Society of Hematology (ASH)
(2015-Present) Michigan Society of Hematology and Oncology (MSHO)
(2012-Present) American Medical Association (AMA)
(2008-Present) American College of Physicians (ACP)
(2012-2015) Ohio State Medical Association (OSMA)

 

 

Board Certification

(2015-Present)  American Board of Internal Medicine

Honors and Awards

(2018) Travel Grant Awarded for abstract presentation: Daratumumab proves safe and highly effective in pretreated AL amyloidosis. Presented at 5th Annual Summit on Hematologic Malignancies, Whistler, BC Canada.
(2017) Trainee Abstract Achievement Award & abstract selected for Highlights of ASH Meetings: Scheduled outpatient red blood cell exchange (RBCX) reduces admissions and complications in sickle cell disease.
(2002) National Merit Scholarship, The Ohio State University, Columbus, OH

Faculty Status

Hem-Onc

← Return to listing